Cover
Cover | Sep. 30, 2023 | Jan. 24, 2023 |
Cover [Abstract] | ||
Document Period End Date | Jan. 24, 2023 | |
Document Type | 8-K | |
Entity Registrant Name | Arrowhead Pharmaceuticals, Inc. | |
Entity File Number | 001-38042 | |
Entity Incorporation, State or Country Code | DE | |
Entity Tax Identification Number | 46-0408024 | |
Entity Address, Address Line One | 177 E. Colorado Blvd | |
Entity Address, Address Line Two | Suite 700 | |
Entity Address, City or Town | Pasadena | |
Entity Address, State or Province | CA | |
Entity Address, Postal Zip Code | 91105 | |
City Area Code | 626 | |
Local Phone Number | 304-3400 | |
Written Communications | false | |
Soliciting Material | false | |
Pre-commencement Tender Offer | false | |
Pre-commencement Issuer Tender Offer | false | |
Title of 12(b) Security | Common Stock, par value $0.001 per share | |
Trading Symbol | ARW | |
Security Exchange Name | NASDAQ | |
Entity Emerging Growth Company | false | |
Entity Central Index Key | 0000879407 | |
Amendment Flag | false | |
Current Fiscal Year End Date | --09-30 |